Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelmnews2022-01-12T01:22:10+00:00January 12th, 2022|The New York Times|
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decisionnews2021-12-31T21:39:22+00:00December 31st, 2021|The New York Times|
How to Cope With Medicare’s Rising Costsnews2021-12-22T10:00:19+00:00December 22nd, 2021|The New York Times|
How to Cope With Medicare’s Rising Costsnews2021-12-22T10:00:19+00:00December 22nd, 2021|The New York Times|
Biden Focuses on How Spending Bill Would Lower Drug Costsnews2021-12-06T23:13:31+00:00December 6th, 2021|The New York Times|
Build Back Better Act Would Patch Holes in Health Coveragenews2021-12-01T10:00:25+00:00December 1st, 2021|The New York Times|
Inflation and Retirement: How to Protect Your Savingsnews2021-11-19T19:25:10+00:00November 19th, 2021|The New York Times|
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.news2021-11-18T04:32:41+00:00November 18th, 2021|The New York Times|
Democrats Reach Deal to Control Drug Prices in Billnews2021-11-02T23:14:56+00:00November 2nd, 2021|The New York Times|
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Votenews2021-11-01T23:14:05+00:00November 1st, 2021|The New York Times|
